Commented Articles

The authors discuss journal articles that they have selected as the past month's most clinically relevant and interesting within their field.

Use the dropdown list below to see commented articles within your area of interest (psychiatry, neurology or both).


Area of Interest:
Page 2 / 57
« Back | Forward »

12 Sep 2008 [ Neurology ]

Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial

Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, Greenop KR, et al.
JAMA 2008; 300 (9); 1027-1037

Commented by Professor Serge Gauthier

18 Aug 2008 [ Neurology ]

Long term effects of Aß42 immunisation in Alzheimer's disease: follow-up of a randomized, placebo-controlled phase I trial

Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, et al.
Lancet 2008; 372 (9634); 216-223

Commented by Professor Serge Gauthier

31 Jul 2008 [ Psychiatry ]

High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study

Bickel H, Gradinger R, Kochs E, Förstl H
Dementia and Geriatric Cognitive Disorders 2008; 26 (1); 26-31. [Epub 2008 Jun 24]

Commented by Professor Serge Gauthier

30 Jun 2008 [ Psychiatry ]

Naltrexone augmentation in OCD: a double-blind placebo-controlled cross-over study

Amiaz R, Fostick L, Gershon A, Zohar J
European Neuropsychopharmacology 2008; 18 (6); 455-461. [Epub 2008 Mar 18]

Commented by Dr David Christmas, Dr Sean Hood & Prof David Nutt

30 Jun 2008 [ Neurology ]

Safety and efficacy of galantamine in subjects with mild cognitive impairment

Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, et al.
Neurology. 2008 May 27;70(22):2024-35. [Epub 2008 Mar 5]

Commented by Professor Serge Gauthier

31 May 2008 [ Psychiatry ]

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers

Journal of Psychopharmacology 2008; 22 (1); 24-32
de Haas SL, de Visser SJ, van der Post JP, Schoemaker RC, van Dyck K, Murphy MG, et al.

Commented by Dr David Christmas, Dr Sean Hood & Prof David Nutt

23 May 2008 [ Neurology ]

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swabb EA, Laughlin MA
Lancet Neurology June; Vol. 7 (6); 483-493. [Epub 2008 Apr30] [DOI:10.1016/S1474-4422(08)70090-5]

Commented by Professor Serge Gauthier

30 Apr 2008 [ Psychiatry ]

Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial

Rickels K, Mathew S, Banov MD, Zimbroff DL, Oshana S, Parsons EC Jr, et al.
Journal of Clinical Psychopharmacology 2008 ; 28 (2); 235-239

Commented by Dr David Christmas, Dr Sean Hood & Prof David Nutt

Page 2 / 57
« Back | Forward »
Last updated: 20.12.2011